 Evolent Health NYSE:EVHs stock had its buy rating reissued by stock analysts at Canaccord Genuity in a note issued to investors on Monday, AnalystRatings.com reports. They currently have a 13.00 target price on the technology companys stock. Canaccord Genuitys target price suggests a potential upside of 28.21 from the stocks previous close. Several other brokerages ... 